SCHEMBL24601546

SCHEMBL24601546

Cc1c(-c2ccccc2)c(C)c(-c2ccccc2)c(-c2ccc3c4c5c6ccccc6n6c7cc(-c8c(-c9ccccc9)c(C)c(-c9ccccc9)c(C)c8-c8ccccc8)ccc7c(c7c8ccccc8n(c3c2)c74)c56)c1-c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAOB P27338 1/20 0.33
LMNA P02545 1/20 0.33
RCE1 Q9Y256 1/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
HSD17B10 Q99714 1/20 0.31
CHEK1 O14757 2/20 0.31
WEE1 P30291 2/20 0.31
BRD4 O60885 1/20 0.31
LIMK1 P53667 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601547 0.94 TSPO (0.34) KDM4EMAPTHPGDALDH1A1KMT2A
SCHEMBL24601656 0.91 KDM4E (0.35) KDM4EMAPTHPGDALDH1A1KMT2A
SCHEMBL24601658 0.85 TSPO (0.36) KDM4EMAPTHPGDALDH1A1KMT2A
SCHEMBL22178597 0.83 MAOB (0.41) KDM4EHPGDALDH1A1MAOBESR1
SCHEMBL24601659 0.82 KMT2A (0.33) KDM4EKMT2ASMN1; SMN2MAOBLMNA
SCHEMBL24601615 0.81 CYP1A2 (0.39) KDM4EMAPTHPGDALDH1A1KMT2A
SCHEMBL24601423 0.81 HSD17B10 (0.35) KDM4EMAPTHPGDALDH1A1KMT2A
SCHEMBL24601624 0.81 HSD17B10 (0.35) KDM4EMAPTHPGDALDH1A1KMT2A
SCHEMBL24601437 0.80 MAOB (0.39) KDM4EHPGDALDH1A1MAOBESR1
SCHEMBL24601799 0.80 HSD17B10 (0.34) KDM4EMAPTHPGDALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 KDM4E 3163/4885MAPT 1370/4885HPGD 2623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.